A good foundation? Regulatory oversight of nanotechnologies using cosmetics as a case study

International Handbook on Regulating Nanotechnologies

Volumn , Issue , 2010, Pages 268-290

  Van Calster, Geert ^a   Bowman, Diana M ^b  

^a EU International Relations and Diplomacy Studies Department   (Belgium)

^b Centre for Health Policy Programs and Economics   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881897249     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (77)

1. Abbott, K.W., D.J. Sylvester and G.E. Marchant (2010), 'Transnational regulation of nanotechnology: Reality or romanticism?', in Graeme A. Hodge, Diana M. Bowman and Andrew D. Maynard (eds), International Handbook on Regulating Nanotechnologies, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 525-44.
2. Bouchemal, K., S. Briancon and E. Perrier (2004), 'Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification', International Journal of Pharmaceutics, 269, 89-100.
3. Bowman, D.M. and G. van Calster (2007), 'Does REACH go too far?', Nature Nanotechnology, 2, 525-6.
4. Bowman, D.M. and G. van Calster (2008), 'Flawless or fallible? A review of the applicability of the European Union's Cosmetics Directive in relation to nano-cosmetics', Studies in Ethics, Law and Technology, 2(3), 1-35.
5. Bowman, D.M. and G. van Calster (2009), 'Smoke that thunders - risk, confusion and regulatory frameworks for new technologies', in Kamilla Kjølberg and Fern Wickson (eds), Nano Meets Macro, London: Pan Stanford Publishing, pp. 313-34.
6. Breggin, L., R. Falkner, N. Jasper, J. Pendergrass and R. Porter (2009), Securing the Promise of Nanotechnologies: Towards Transatlantic Regulatory Cooperation, London: Royal Institute of International Affairs.
7. Chaudhry, Q., J. Blackburn, P. Floyd et al. (2006), Final Report: A Scoping Study to Identify Gaps in Environmental Regulation for the Products and Applications of Nanotechnologies, London: Defra.
8. Chaudhry, Q., H. Bouwmeester and R.F. Hertel (2010), 'The current risk assessment paradigm in relation to the regulation of nanotechnologies', in Graeme A. Hodge, Diana M. Bowman and Andrew D. Maynard (eds), International Handbook on Regulating Nanotechnologies, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 124-43.
9. Chi, K.-T. and J. Kinderlerer (2008), 'Silent victims?', in Johann S. Ach and Christian Weidemann (eds), Size Matters: Ethical, Legal and Social Aspects of Nanobiotechnology and Nano Medicine, Münsteraner Bioethik-Studien 8, Berlin: LIT Verleg, pp. 213-48.
10. D'Silva, J. and G. van Calster (2009), 'Taking temperature - a review of European Union regulation in nanomedicine', European Journal of Health Law, 16(3), 249-69.
11. Environmental Defense (2005), Letter of Understanding - DuPont - Environmental Defense Framework for Responsible Nanotechnology Standards, Washington, DC: Environmental Defense and DuPont.
12. Environmental Defense and DuPont (2007), Nano Risk Framework, New York: EDF.
13. Environmental Protection Agency (2000), Nanomaterial Case Studies: Nanoscale Titanium Dioxide in Water Treatment and in Topical Sunscreen, draft case study, Washington, DC: Office of Research and Development, EPA.
14. Environmental Protection Agency (2007), EPA Nanotechnology White Paper, Washington, DC: EPA.
15. ETC Group (2004), Down on the Farm, Ottawa: ETC Group.
16. EuroActiv.com (2009), Germany Opposed to 'Nano' Label for Cosmetics, 24 November, accessed 1 December 2009 at www.euractiv.com/en/enterprise-jobs/germany-opposednano-label-cosmetics/article-187583.
17. European Commission (2008a), Regulatory Aspects of Nanomaterials, Brussels: EC.
18. European Commission (2008b), Recommendation of 7 February 2008 on a Code of Conduct for responsible nanosciences and nanotechnologies research, C(2008) 424, Brussels: EC.
19. European Commission (2008c), Regulatory Aspects of Nanomaterials: Summary of legislation in relation to health, safety and environment aspects of nanomaterials, regulatory research needs and related measures, Brussels: EC.
20. European Parliament (2009), Resolution of 24 April 2009 on regulatory aspects of nanomaterials, P6_TA(2009)0328, Brussels: EP.
21. Falkner, R., L. Breggin, N. Jaspers, J. Pendergrass and R. Porter (2010), 'International coordination and cooperation: the next agenda in nanomaterials regulation', in Graeme A. Hodge, Diana M. Bowman and Andrew D. Maynard (eds), International Handbook on Regulating Nanotechnologies, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 508-24.
22. Faunce, T. and K. Shats (2007), 'Researching safety and cost-effectiveness in the life cycle of nanomedicine', Journal of Law and Medicine, 15, 128-35.
23. Fleming, N. (2006), 'Women buying creams made of tiny particles "used as guinea pigs"', The Daily Telegraph, London, 5 May, p. 6.
24. Food and Drug Administration (FDA) (2006), Is It a Cosmetic, a Drug, or Both? (or Is It a Soap?), Washington DC: FDA, accessed 23 March 2009 at vm.cfsan.fda.gov/~dms/cos-218.html.
25. Food Safety Authority of Ireland (FSAI) (2008), The Relevance for Food Safety of Applications of Nanotechnology in the Food and Feed Industries, Dublin: FSAI.
26. Food Standards Agency (FSA) (2008), A Review of the Potential Implications of Nanotechnologies for Regulations and Risk Assessment in Relation to Food, London: FSA.
27. Friends of the Earth Australia (FoE) (2006), Nanomaterials, Sunscreens and Cosmetics: Small Ingredients, Big Risks, Melbourne: FoE Australia and FoEUS.
28. Gaspar, R. (2010), 'Therapeutic products: regulating drugs and medical devices', in Graeme A. Hodge, Diana M. Bowman and Andrew D. Maynard (eds), International Handbook on Regulating Nanotechnologies, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 291-320.
29. Gergely, A. and L. Coroyannakis (2009), 'Nanotechnology in the EU cosmetics regulation', Household and Personal Care Today, 3, 28-30.
30. Guterres, S.S., M.P. Alves and A.R. Pohlmann (2007), 'Polymeric nanoparticles, nanospheres and nanocapsules for cutaneous applications', Drug Target Insights, 2, 147-57.
31. Health and Safety Executive (HSE) (2006), Review of the Adequacy of Current Regulatory Regimes to Secure Effective Regulation of Nanoparticles Created by Nanotechnology: The Regulations Covered by HSE, London: HSE.
32. Hoet, P., H.I. Bruske-Hohlfeld and O. Salata (2004), 'Review: nanoparticles - known and unknown health effects', Journal of Nanobiotechnology, 2(12), 1-15.
33. Honeywell-Nguyen, P.L. and J.A. Bouwstra (2005), 'Vesicles as a tool for transdermal and dermal delivery', Drug Discovery Today: Technologies, 2(1), 67-74.
34. International Centre for Technology Assessment (ICTA) (2008), Groups Demand EPA Stop Sale of 200+ Potentially Dangerous Nano-Silver Products, Washington, DC: ICTA.
35. International Risk Governance Council (IRGC) (2008), Risk Governance of Nanotechnology Applications in Food and Cosmetics, Geneva: IRGC.
36. International Risk Governance Council (2009), Appropriate Risk Governance Strategies for Nanotechnology Applications in Food and Cosmetics, Geneva: IRGC.
37. Jasanoff, S. (2005), Designs on Nature: Science and Democracy in Europe and the United States, Princeton, NJ: Princeton University Press.
38. Jenning, V., A. Gysler, M. Schafer-Korting, S.H. Gohla (2000), 'Vitamin A loaded solid lipid nanoparticles for topic use: occlusive properties and drug targeting to the upper skin', European Journal of Pharmaceutics and Biopharmaceutics, 49, 211-18.
39. Kafi, R., H.S.R. Kwak and W.E. Schumacher (2007), 'Improvement of naturally aged skin with vitamin A (retinol)', Archives of Dermatology, 143(5), 606-12.
40. Kandlikar, M., G. Ramachandran, A.D. Maynard et al. (2007), 'Health risk assessment for nanoparticles: a case for using expert judgment', Journal of Nanoparticle Research, 9, 137-56.
41. Kimbrell, G.A. (2006), 'Nanomaterial consumer products and FDA regulation: regulatory challenges and necessary amendments', Nanotechnology Law & Business, 3, 329-38.
42. Kimbrell, G.A. (2007), 'Nanotechnology and nanomaterial personal care products: necessary oversight and recommendations', in C. I. Betton (ed), Global Regulatory Issues for the Cosmetics Industry, New York: William Andrew, pp. 117-54.
43. Lecrenier, S. (2008), Letter to Mr Heerink regarding use of nanoparticles in cosmetics, 11 April, from Enterprise and Industry Directorate-General, European Commission, accessed 13 December 2009 at chemicalwatch.com/downloads/Comm%20consultation%20on%20nanoparticles.pdf.
44. Levi-Faur, D. and H. Comaneshter (2007), 'The risks of regulation and the regulation of risks: the governance of nanotechnology', in Graeme A. Hodge, Diana M. Bowman and Karinne Ludlow (eds), New Global Regulatory Frontiers in Regulation: The Age of Nanotechnology, Cheltenham, UK and Northampton, MA, USA: Edward Elgar, pp. 149-65.
45. Ludlow, K., D.M. Bowman and G.A. Hodge (2007), A Review of Possible Impacts of Nanotechnology on Australia's Regulatory Framework, Melbourne, VIC: Monash Centre for Regulatory Studies.
46. Lupo, M.P. (2001), 'Antioxidants and vitamins in cosmetics', Clinics in Dermatology, 19(4), 467-73.
47. Lux Research (2009), Nanotech's Evolving Environmental, Health, and Safety Landscape: The Regulations Are Coming, New York: Lux Research.
48. Maynard, A.D. (2007), 'Nanotechnology: the next big thing, or much ado about nothing?', The Annals of Occupational Hygiene, 51, 1-12.
49. Maynard, A.D., R.J. Aitken, T. Butz, et al. (2006), 'Safe handling of nanotechnology', Nature, 444, 267-9.
50. Miller, G. and R. Senjen (2008), Out of the Laboratory and on to Our Plates: Nanotechnology in Food & Agriculture, Melbourne, VIC: FoE Australia, Europe and US.
51. Morganti, P., E. Ruocco, R. Wolf and V. Ruocco (2001), 'Percutaneous absorption and delivery systems', Clinics in Dermatology, 19(4), 489-501.
52. Muller, R.H., K. Mader, and S.H. Gohla (2000), 'Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art', European Journal of Pharmaceutics and Biopharmaceutics, 50, 161-77.
53. Nohynek, G.J., J. Lademann, C. Ribaud and M.S. Roberts (2007), 'Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety', Critical Reviews in Toxicology, 37(3), 251-77.
54. Nohynek, G.J., E.K. Dufour and M.S. Roberts (2008), 'Nanotechnology, cosmetics and the skin: is there a health risk?', Skin Pharmacology and Applied Skin Physiology, 21, 136-9.
55. Oberdörster, E. (2004), 'Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass', Environmental Health Perspectives, 112(10), 1058-62.
56. Oberdörster, G., A.D. Maynard, K. Donaldson, V. Castronova, J. Fitzpatrick, K. Ausman, J.M. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N.A. Monteiro-Riviere, D. Warheit and H. Yang (2005), 'Review: principles for characterizing the potential human health effects from exposure to nanomaterials; elements of a screening strategy', Particle and Fibre Toxicology, 2(8), 1-35.
57. Organisation for Economic Co-operation and Development (2008), Nanotechnologies at the OECD, Paris: OECD.
58. Project on Emerging Nanotechnologies (2009), Nano-Product Inventory - Consumer Products, accessed 13 October 2009 at www.nanotechproject.org/consumerproducts.
59. Rocks, S., S. Pollard, R. Dorey, L. Levy, P. Harrison and R. Handy (2008), Comparison of Risk Assessment Approaches for Manufactured Nanomaterials, Cranfield: Cranfield University.
60. Schlyter, C. (2009), Draft Report for the European Parliament Committee on the Environment, Public Health and Food Safety on Regulatory Aspects of Nanomaterials, 2008/2208 (INI), Brussels: EP.
61. Scientific Committee on Consumer Products (2005), Scientific Committee on Consumer Products (SCCP) - Request for a Scientific Opinion: Safety of Nanomaterials in Cosmetic Products, Brussels: Health and Consumer Protection Directorate-General.
62. Scientific Committee on Consumer Products (2006), The SCCP's Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation, 6th revision, Brussels: Health and Consumer Protection Directorate-General.
63. Scientific Committee on Consumer Products (2007), Preliminary Opinion on Safety of Nanomaterials in Cosmetic Products, Brussels: Health and Consumer Protection Directorate-General.
64. Scientific Committee on Emerging and Newly Identified Health Risks (2006), Modified Opinion (After Public Consultation) on the Appropriateness of Existing Methodologies to Assess the Potential Risks Associated with Engineered and Adventitious Products of Nanotechnologies, Brussels: EC.
65. Scientific Committee on Emerging and Newly Identified Health Risks (2009), Risk Assessment of Products of Nanotechnologies, Brussels: EC.
66. Senjen, R. and I. Illuminato (2009), Nano & Biocidal Silver, Melbourne, VIC: Friends of the Earth Australia and FoEUS.
67. Sinclair, D. (1997), 'Self-regulation versus command and control? Beyond false dichotomies', Law & Policy, 19(4), 529-59.
68. Small Times (2002), 'The nanoscience behind beauty is serious business at L'Oreal', accessed 9 October 2007 at: www.smalltimes.com/Articles/Article_Display.cfm?ARTICLE_ID=268424&p=109.
69. Soppimath, K.S., T.M. Aminabhavi, A.R. Kulkarni and W.E. Rudzinski (2001), 'Biodegradable polymeric nanoparticles as drug delivery devices', Journal of Controlled Release, 70(1-2), 1-20.
70. Standing Committee on State Development (2008), Nanotechnology in New South Wales, Sydney, NSW: Legislative Council.
71. Sylvester, D.J., K.W. Abbott and G.E. Marchant (2009), 'Not again! Public perception, regulation, and nanotechnology', Regulation & Governance, 3, 165-85.
72. Taylor, M.R. (2006), Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs?, Washington, DC : Project on Emerging Nanotechnologies.
73. Therapeutic Goods Administration (TGA) (2006), A Review of the Scientific Literature on the Safety of Nanoparticulate Titanium Dioxide and Zinc Oxide in Sunscreens, Canberra: TGA.
74. Therapeutic Goods Administration (2009), A Review of the Scientific Literature on the Safety of Nanoparticulate Titanium Dioxide or Zinc Oxide in Sunscreens, Canberra: TGA.
75. van Calster, G. (2008), 'Risk regulation, EU law and emerging technologies: smother or smooth?, NanoEthics, 2(1), 61-71.
76. van Calster, G., D.M. Bowman and J. D'Silva (2008), 'Sufficient or deficient? A review of the adequacy of current european legislative instruments for regulating nanotechnologies across three industry sectors', paper presented at the conference, Tilting Perspectives on Regulating Technologies, Tilburg, 10-11 December.
77. Which? (2008), Small Wonder? Nanotechnology and Cosmetics, London: Which?